Manufacturing

Welcome to the Cell & Gene Therapy and Thermo Fisher Scientific Learning Center

Process Development & cGMP Manufacturing hub

Optimizing upstream processing to improve consistency and scalability in viral vector production

Optimizing upstream processing to improve consistency and scalability in viral vector production

Katerina Rigaki

Next-gen immunotherapy: a guide for CGT developers

Next-gen immunotherapy: a guide for CGT developers

Essential equipment for advancing cell and gene therapy: innovations in incubation, monitoring, and cold storage

Essential equipment for advancing cell and gene therapy: innovations in incubation, monitoring, and cold storage

Exploring strategies for scaling up allogeneic natural killer cell therapy

Exploring strategies for scaling up allogeneic natural killer cell therapy

The path to PAT: the role of process analytical technologies in advancing CAR-T therapy production

The path to PAT: the role of process analytical technologies in advancing CAR-T therapy production

Next-gen cell therapy manufacturing: leveraging flexibility and automation for success

Next-gen cell therapy manufacturing: leveraging flexibility and automation for success

David Shaw, Fred Parietti, Carl Dargitz

Innovator Insight

Digitalization and data analytics: shaping the future of cell bioprocessing

Digitalization and data analytics: shaping the future of cell bioprocessing

Harnessing AI and omics for next-generation gene therapy manufacturing

Harnessing AI and omics for next-generation gene therapy manufacturing

Richard Braatz, Irene Rombel

Navigating analytical and regulatory hurdles in early-phase clinical cell therapy development

Navigating analytical and regulatory hurdles in early-phase clinical cell therapy development

1
2
3
4
5
6
7
8
9
10
...
>
>>

Actionable insights for overcoming CMC challenges in TIL therapy: GRIT’s strategic approach

Actionable insights for overcoming CMC challenges in TIL therapy: GRIT’s strategic approach

Combining CRISPR and transposon-based technologies for improved sdAb-based CAR-T therapies

Combining CRISPR and transposon-based technologies for improved sdAb-based CAR-T therapies

Begoña Diez Cabezas, Juan Roberto Rodriguez-Madoz

Optimizing plasmid DNA purification: strategies for reliable and expandable processes

Optimizing plasmid DNA purification: strategies for reliable and expandable processes

Christy Franco, Jasmina Puc

Non-viral GMP manufacturing for engineered cells at clinical and commercial scale

Non-viral GMP manufacturing for engineered cells at clinical and commercial scale

Leif Anderson, Chris Abraham

Optimizing for faster quality control in cell therapies: leveraging rapid detection methods

Optimizing for faster quality control in cell therapies: leveraging rapid detection methods

Srinath Kashi Ranganath

To 1000L and beyond: streamlining AAV manufacturing with transfection complex stabilization

To 1000L and beyond: streamlining AAV manufacturing with transfection complex stabilization

Navigating the transition from research to clinical-scale cell therapy manufacture

Navigating the transition from research to clinical-scale cell therapy manufacture

Steven Feldman, Johannes Fruehauf, Mary Ann Santos

A case study in faster, higher-quality pDNA manufacturing

A case study in faster, higher-quality pDNA manufacturing

Xiangming Gu, Lucas Smith

Flow with confidence: innovations that foster flexibility and scale in closed-system manufacturing

Flow with confidence: innovations that foster flexibility and scale in closed-system manufacturing

1
2
3
4
5
6
7
8
9
10
...
>
>>